FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Merck | HPV | Gardasil | FDA rejection
Syndicate content

FDA rejects Merck's Gardasil for women over 26

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


The FDA has rejected Merck's ($MRK) request to market its HPV vaccine Gardasil to women between the ages of 27 and 45. The company had hoped the expanded use could boost slumping sales, which dropped 12 percent to $988 million in 2010, despite the 2009 addition of men and boys ages 9 to 26 to the potential patient list. Recently, the shot was also approved for anal cancer prevention.

According to Merck's release, the vaccine failed to provide adequate results for trial patients and also didn't prevent cervical dysplasia or other HPV-related diseases in the 27 to 45 age range. The FDA added this data to the prescribing information.

Merck first approached the FDA for approval among older women in 2008, but the agency postponed its decision three times as it asked for more information from the company. Gardasil faces competition from GlaxoSmithKline's Cervarix, which won approval in late 2009.

- here's the Merck release
- read the Bloomberg article
- see the post from the Wall Street Journal

Related Articles:
Study: Gardasil effective in boys, men
Anal cancer vax gets FDA green light
HPV shot provides sustained protection against pre-cancerous growths

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Merck   HPV   Gardasil   FDA rejection  


Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.